STOCK TITAN

Zynex Medical to Participate in Upcoming Investor Conferences

(Neutral)
(Neutral)
Tags
conferences

Rhea-AI Summary

Zynex, a leading medical technology company, will participate in two key investor conferences in May 2022. The management will present virtually at the H.C. Wainwright Annual Global Investment Conference on May 24, 2022, at 7 AM ET. Additionally, Zynex will present at the UBS Global Healthcare Conference on May 25, 2022, at 12:15 PM ET. Investors can access webcasts of both events through the company's investor relations website. Zynex specializes in non-invasive medical devices for pain management, rehabilitation, and patient monitoring.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

News Market Reaction – ZYXI

-4.84%
-4.84% Session move

In the trading session that priced this news, ZYXI declined 4.84%, reflecting a moderate negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

ENGLEWOOD, Colo., May 10, 2022 /PRNewswire/ -- Zynex, Inc. (Nasdaq: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, today announced that it will participate in two upcoming investor conferences.

Zynex management will be participating virtually in the H.C. Wainwright Annual Global Investment Conference. Interested parties can access the live and archived webcast on the Events section of the website at https://zynexmed.investorroom.com/ir-home on Tuesday, May 24, 2022, at 7am ET.

Zynex management is also scheduled to present at the UBS Global Healthcare Conference on Wednesday, May 25, 2022, at 12:15 PM ET. Interested parties can access the live and archived webcast at https://zynexmed.investorroom.com/ir-home.

About Zynex, Inc.
Zynex, founded in 1996, develops, manufactures, markets, and sells medical devices used for pain management and rehabilitation as well as non-invasive fluid, sepsis and laser-based pulse oximetry monitoring systems for use in hospitals. For additional information, please visit: www.zynex.com 

Investor Contact
Gilmartin Group
650 Fifth Ave., Suite 2720
New York, NY 10019
IR@zynex.com

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/zynex-medical-to-participate-in-upcoming-investor-conferences-301543538.html

SOURCE Zynex

FAQ

What is Zynex's participation in the upcoming investor conferences?

Zynex will participate in the H.C. Wainwright Annual Global Investment Conference on May 24, 2022, and the UBS Global Healthcare Conference on May 25, 2022.

When will Zynex present at the H.C. Wainwright Annual Global Investment Conference?

Zynex will present on May 24, 2022, at 7 AM ET.

What time is Zynex's presentation at the UBS Global Healthcare Conference?

Zynex is scheduled to present at 12:15 PM ET on May 25, 2022.

How can investors access Zynex's conference webcasts?

Investors can access the live and archived webcasts on Zynex's investor relations website.

What type of medical devices does Zynex specialize in?

Zynex specializes in non-invasive medical devices for pain management, rehabilitation, and patient monitoring.